Detecting and classifying copy number variation
AssigneeVerinata Health, Inc.
InventorsRichard P. Rava, Anupama Srinivasan
Life of this patent
Estimating the term…
Loading patent…
AssigneeVerinata Health, Inc.
InventorsRichard P. Rava, Anupama Srinivasan
Estimating the term…
The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.
A method for classifying a copy number variation in a fetal genome, the method comprising:
A computer program product comprising a non-transitory computer readable medium on which is provided program instructions for classifying a copy number variation in a fetal genome, the program instructions comprising:
A system for classifying a copy number variation in a fetal genome, the system comprising:
Dependencies are inferred from the claim text.